mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.07 |
mRNA |
BRD-K66532283 |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.08 |
mRNA |
Z-LLNle-CHO |
GDSC1000 |
pan-cancer |
AAC |
-0.084 |
0.08 |
mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.08 |
mRNA |
OSI-930 |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.08 |
mRNA |
XMD15-27 |
GDSC1000 |
pan-cancer |
AAC |
-0.061 |
0.08 |
mRNA |
MP470 |
GDSC1000 |
pan-cancer |
AAC |
0.061 |
0.08 |
mRNA |
Mdivi-1 |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.08 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.08 |
mRNA |
ABT-888 |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.08 |